arginine has been researched along with quinpirole in 7 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (14.29) | 18.2507 |
2000's | 2 (28.57) | 29.6817 |
2010's | 3 (42.86) | 24.3611 |
2020's | 1 (14.29) | 2.80 |
Authors | Studies |
---|---|
Brus, R; Kostrzewa, RM; Szkilnik, R | 1 |
Kayir, H; Uzbay, IT | 1 |
Cho, EY; Kim, JH; Kim, KM; Min, C; Park, JH | 1 |
Hoque, KE; West, AR | 1 |
Borroto-Escuela, DO; Ciruela, F; Fernández-Dueñas, V; Fuxe, K; Gómez-Soler, M; Jacobson, KA; Kumar, ST | 1 |
Lee, L; Nickla, DL; Totonelly, K | 1 |
Fazli-Tabaei, S; Khakpai, F; Zarrindast, MR | 1 |
7 other study(ies) available for arginine and quinpirole
Article | Year |
---|---|
Nitric oxide (NO) and central dopamine (DA) D3 receptor reactivity to quinpirole in rats.
Topics: Animals; Arginine; Dopamine Agonists; Enzyme Inhibitors; Ergolines; Female; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Quinpirole; Rats; Rats, Wistar; Receptors, Dopamine D2; Receptors, Dopamine D3; Yawning | 1996 |
Bromocriptine and quinpirole, but not 7-OH-DPAT or SKF 38393, potentiate the inhibitory effect of L-NAME on ethanol-induced locomotor activity in mice.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Arginine; Bromocriptine; Dopamine Agonists; Dose-Response Relationship, Drug; Drug Synergism; Enzyme Inhibitors; Ethanol; Male; Mice; Motor Activity; NG-Nitroarginine Methyl Ester; Nitric Oxide; Quinpirole; Receptors, Dopamine D2; Receptors, Dopamine D3; Tetrahydronaphthalenes | 2003 |
Characterization of functional roles of DRY motif in the 2nd intracellular loop of dopamine D2 and D3 receptors.
Topics: Amino Acid Motifs; Apomorphine; Arginine; Aspartic Acid; Cell Line; Cell Membrane; Cyclic AMP; Dopamine Agonists; Dopamine Antagonists; Dose-Response Relationship, Drug; Humans; Mutation; Protein Conformation; Protein Structure, Tertiary; Protein Transport; Quinpirole; Receptors, Dopamine D2; Receptors, Dopamine D3; Signal Transduction; Spiperone; Sulpiride; Transfection | 2008 |
Dopaminergic modulation of nitric oxide synthase activity in subregions of the rat nucleus accumbens.
Topics: Animals; Arginine; Benzazepines; Dopamine; Dopamine Agonists; Dopamine Antagonists; Dopamine D2 Receptor Antagonists; Dopaminergic Neurons; Male; Nitric Oxide Synthase; Nucleus Accumbens; Piperazines; Quinpirole; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D1; Receptors, Dopamine D2; Receptors, N-Methyl-D-Aspartate; Salicylamides | 2012 |
Molecular determinants of A2AR-D2R allosterism: role of the intracellular loop 3 of the D2R.
Topics: Adenosine A2 Receptor Agonists; Adenosine A2 Receptor Antagonists; Allosteric Regulation; Arginine; Dopamine Agonists; HEK293 Cells; Humans; Intracellular Fluid; Mutagenesis, Site-Directed; Protein Binding; Protein Structure, Tertiary; Quinpirole; Receptor, Adenosine A2A; Receptors, Dopamine D2 | 2012 |
Nitric oxide synthase inhibitors prevent the growth-inhibiting effects of quinpirole.
Topics: Animals; Animals, Newborn; Arginine; Chickens; Disease Models, Animal; Dopamine Agonists; Drug Combinations; Eye; Injections, Intraocular; Myopia; Nitric Oxide Synthase; Ornithine; Quinpirole; Refraction, Ocular; Sensory Deprivation; Ultrasonography | 2013 |
Synergistic effect between quinpirole and L-NAME as well as sulpiride and L-arginine on the modulation of anxiety and memory processes in the 6-OHDA mouse model of Parkinson's disease: An isobologram analysis.
Topics: Adrenergic Agents; Animals; Anxiety; Arginine; Disease Models, Animal; Dopamine Agonists; Dopamine Antagonists; Dopamine D2 Receptor Antagonists; Drug Therapy, Combination; Enzyme Inhibitors; Male; Memory; Mice; NG-Nitroarginine Methyl Ester; Nitric Oxide; Oxidopamine; Parkinson Disease; Quinpirole; Receptors, Dopamine D2; Sulpiride | 2021 |